Skip to Content

850 Results Found

  • Article
  • Open Access
24 Citations
5,527 Views
11 Pages

Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population

  • Shelby Barnett,
  • Julie Errington,
  • Julieann Sludden,
  • David Jamieson,
  • Vianney Poinsignon,
  • Angelo Paci and
  • Gareth J. Veal

16 March 2021

Infants and young children represent an important but much understudied childhood cancer patient population. The pharmacokinetics and pharmacogenetics of the widely used anticancer prodrug cyclophosphamide were investigated in children <2 years of...

  • Article
  • Open Access
14 Citations
3,480 Views
12 Pages

Asciminib Mitigates DNA Damage Stress Signaling Induced by Cyclophosphamide in the Ovary

  • Luca Mattiello,
  • Giulia Pucci,
  • Francesco Marchetti,
  • Marc Diederich and
  • Stefania Gonfloni

30 January 2021

Cancer treatments can often adversely affect the quality of life of young women. One of the most relevant negative impacts is the loss of fertility. Cyclophosphamide is one of the most detrimental chemotherapeutic drugs for the ovary. Cyclophosphamid...

  • Article
  • Open Access
1 Citations
1,729 Views
19 Pages

Influence of Puncture Devices on the Accuracy of Cyclophosphamide Dosing for Chemotherapy Administration

  • Susana Carvalho,
  • Andreia Cardoso,
  • Débora Ferreira,
  • Diana Dias da Silva and
  • Fernando Moreira

Background/Objectives: Cyclophosphamide is one of the most commonly used cytotoxic drugs in chemotherapy protocols. Its preparation in the hospital setting involves handling concentrated solutions, which pose occupational exposure risks and potential...

  • Article
  • Open Access
18 Citations
5,906 Views
12 Pages

Genetic Polymorphism of GSTP-1 Affects Cyclophosphamide Treatment of Autoimmune Diseases

  • Péter Hajdinák,
  • Melinda Szabó,
  • Emese Kiss,
  • Lili Veress,
  • Lívius Wunderlich and
  • András Szarka

28 March 2020

Cyclophosphamide is one of the most potent and reliable anti-cancer and immunosuppressive drugs. In our study, 33 individuals with different autoimmune diseases were treated with cyclophosphamide according to standard protocols. The responses to the...

  • Article
  • Open Access
925 Views
23 Pages

Retinoic Acid and Calcitriol Protect Mouse Primordial Follicles from Cyclophosphamide Treatment-Induced Apoptosis

  • Sihui He,
  • Xiaodan Zhang,
  • Wenjun Zhou,
  • Ye Chen,
  • Fengxin Liu,
  • Weiyong Wang,
  • Hongwei Wei,
  • Yan Du and
  • Meijia Zhang

Chemotherapy causes primordial follicle apoptosis, resulting in premature ovarian insufficiency (POI) and infertility. In this study, we found that intraperitoneal injection of retinoic acid (RA) and calcitriol partially reversed the cyclophosphamide...

  • Article
  • Open Access
110 Citations
11,430 Views
12 Pages

Immunomodulatory Effect of Tremella Polysaccharides against Cyclophosphamide-Induced Immunosuppression in Mice

  • Yalin Zhou,
  • Xiaoyong Chen,
  • Ruokun Yi,
  • Guijie Li,
  • Peng Sun,
  • Yu Qian and
  • Xin Zhao

25 January 2018

Polysaccharides are closely associated with immune regulation, but there are different polysaccharide effects from different sources. In this study, the aim was to investigate the effect of tremella polysaccharides (TP) in cyclophosphamide-induced im...

  • Article
  • Open Access
9 Citations
3,431 Views
12 Pages

Sesamin’s Therapeutic Actions on Cyclophosphamide-Induced Hepatotoxicity, Molecular Mechanisms, and Histopathological Characteristics

  • Abdulmajeed M. Jali,
  • Mohammad Firoz Alam,
  • Ali Hanbashi,
  • Wedad Mawkili,
  • Basher M. Abdlasaed,
  • Saeed Alshahrani,
  • Abdullah M. Qahl,
  • Ahmad S. S. Alrashah and
  • Hamad Al Shahi

Cyclophosphamide, an alkylating agent integral to specific cancer chemotherapy protocols, is often curtailed in application owing to its significant hepatotoxic side effects. Therefore, this study was conducted to assess the hepatoprotective potentia...

  • Article
  • Open Access
67 Citations
6,718 Views
15 Pages

Hidrox® Counteracts Cyclophosphamide-Induced Male Infertility through NRF2 Pathways in a Mouse Model

  • Roberta Fusco,
  • Angela Trovato Salinaro,
  • Rosalba Siracusa,
  • Ramona D’Amico,
  • Daniela Impellizzeri,
  • Maria Scuto,
  • Maria Laura Ontario,
  • Roberto Crea,
  • Marika Cordaro and
  • Vittorio Calabrese
  • + 2 authors

Background: Every year, men use cyclophosphamide to treat various cancers and autoimmune diseases. On the one hand, this chemotherapy often has the beneficial effect of regressing the tumor, but on the other hand, it leads to infertility due to exces...

  • Article
  • Open Access
13 Citations
4,988 Views
12 Pages

Echinacea purpurea Alleviates Cyclophosphamide-Induced Immunosuppression in Mice

  • Ha-Rim Kim,
  • Ye-Seul Kim,
  • Dong-Ryung Lee,
  • Bong-Keun Choi,
  • Kang-Beom Kwon and
  • Gi-Sang Bae

23 December 2021

Echinacea purpurea (EP) has been widely used to treat upper respiratory infections, influenza, and the common cold. It can also exert various pharmacological activities, such as anti-inflammatory and anti-allergic effects. However, the potential of E...

  • Review
  • Open Access
12 Citations
3,313 Views
15 Pages

Is Post-Transplant Cyclophosphamide the New Methotrexate?

  • Alberto Mussetti,
  • Annalisa Paviglianiti,
  • Rocio Parody and
  • Anna Sureda

12 August 2021

Introducing post-transplant, cyclophosphamide (PT-Cy) graft-versus-host disease (GVHD) prophylaxis in the setting of haploidentical donor transplantation has marked the most important advance in allogeneic hematopoietic cell transplantation (alloHCT)...

  • Review
  • Open Access
6 Citations
4,238 Views
14 Pages

Effects of the Alkylating Agent Cyclophosphamide in Potentiating Anti-Tumor Immunity

  • Benjamin D. Gephart,
  • Don W. Coulter and
  • Joyce C. Solheim

Cyclophosphamide (CPX) is an alkylating agent commonly used for various hematological and solid malignancies. In addition to its use as a cytotoxic agent to directly kill tumor cells, numerous immunomodulatory properties of CPX in the tumor microenvi...

  • Article
  • Open Access
4 Citations
2,951 Views
16 Pages

Add-On Cyclic Angiotensin-(1-7) with Cyclophosphamide Arrests Progressive Kidney Disease in Rats with ANCA Associated Glomerulonephritis

  • Domenico Cerullo,
  • Daniela Rottoli,
  • Daniela Corna,
  • Mauro Abbate,
  • Ariela Benigni,
  • Giuseppe Remuzzi and
  • Carlamaria Zoja

5 August 2022

Rapidly progressive crescentic glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies (ANCA-GN) is a major cause of renal failure. Current immunosuppressive therapies are associated with severe side effects, intensifying the need f...

  • Article
  • Open Access
6 Citations
3,635 Views
15 Pages

22 February 2024

This study investigates the immunomodulatory potential of Galium aparine L. (GAE) in immunodeficient animals. In this study, animals were categorized into five groups: the normal group, CYP group (cyclophosphamide intraperitoneal injection), GA5 grou...

  • Article
  • Open Access
21 Citations
5,081 Views
12 Pages

Therapeutic Potential of Capsaicin against Cyclophosphamide-Induced Liver Damage

  • Mohammad Firoz Alam,
  • Ahmed O. Ajeibi,
  • Majed H. Safhi,
  • Ahmad J. A. Alabdly,
  • Saeed Alshahrani,
  • Hina Rashid,
  • Marwa Qadri,
  • Abdulmajeed M. Jali,
  • Saud Alqahtani and
  • Tarique Anwer
  • + 3 authors

24 January 2023

Cyclophosphamide (CPM) is a classical alkylating agent used in different cancer chemotherapy regimens and is restricted due to severe adverse effects, including hepatotoxicity. Natural or plant-derived antioxidants such as capsaicin were utilized in...

  • Article
  • Open Access
32 Citations
5,991 Views
8 Pages

Fucoidan and Fucosylated Chondroitin Sulfate Stimulate Hematopoiesis in Cyclophosphamide-Induced Mice

  • Natalia Anisimova,
  • Nadezhda Ustyuzhanina,
  • Maria Bilan,
  • Fedor Donenko,
  • Anatolii Usov,
  • Mikhail Kiselevskiy and
  • Nikolay Nifantiev

30 September 2017

Application of cytostatics in cancer patients’ chemotherapy results in a number of side effects, including the inhibition of various parts of hematopoiesis. Two sulfated polysaccharides, fucoidan from the seaweed Chordaria flagelliformis (PS-Fuc) and...

  • Article
  • Open Access
18 Citations
3,939 Views
14 Pages

Capsaicin Ameliorates the Cyclophosphamide-Induced Cardiotoxicity by Inhibiting Free Radicals Generation, Inflammatory Cytokines, and Apoptotic Pathway in Rats

  • Rayan A. Ahmed,
  • Mohammad Firoz Alam,
  • Saeed Alshahrani,
  • Abdulmajeed M. Jali,
  • Abdullah M. Qahl,
  • Mohammad Khalid,
  • Hisham M. A. Muzafar,
  • Hussain N. Alhamami and
  • Tarique Anwer

14 March 2023

Cyclophosphamide is an antineoplastic agent that has a broad range of therapeutic applications; however, it has numerous side effects, including cardiotoxicity. Furthermore, chili peppers contain a substance called capsaicin, having antioxidant and a...

  • Article
  • Open Access
14 Citations
2,742 Views
15 Pages

30 August 2023

Cyclophosphamide causes side effects in cancer patients, including hepatotoxicity. Probiotics have recently emerged as potential approaches for the administration of many diseases. This study aimed to evaluate the protective effects of Lactiplantibac...

  • Article
  • Open Access
14 Citations
3,932 Views
14 Pages

Hematopoietic Effects of Angelica gigas Nakai Extract on Cyclophosphamide-Induced Myelosuppression

  • Mincheol Kang,
  • Seojin Park,
  • Yuseong Chung,
  • Je-Oh Lim,
  • Jae Seon Kang and
  • Jun Hong Park

12 December 2022

Myelosuppression is a major adverse effect of chemotherapy. With the increasing number of cancer patients worldwide, there is a growing interest in therapeutic approaches that reduce the adverse effects of chemotherapy. Angelica gigas Nakai (AGN) roo...

  • Article
  • Open Access
4 Citations
4,376 Views
14 Pages

6 May 2024

Numerous studies have investigated the immunomodulatory effects of yogurt, but the underlying mechanism remained elusive. This study aimed to elucidate the alleviating properties of yogurt on immunosuppression and proposed the underlying mechanism wa...

  • Article
  • Open Access
2 Citations
2,691 Views
15 Pages

24 February 2023

Tumor cells express antigens that should induce immune-mediated rejection; however, spontaneous rejection of established tumors is rare. Recent evidence suggests that patients suffering from cancer exhibit an elevation in regulatory T cells populatio...

  • Article
  • Open Access
1 Citations
1,273 Views
14 Pages

A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors

  • Jessica Boklan,
  • Anne-Marie Langevin,
  • Kevin Bielamowicz,
  • Kathleen Neville,
  • Tanya Trippett,
  • Valerie Brown,
  • Steven G. DuBois,
  • Francis Eshun,
  • Jonathan Gelfond and
  • Norman J. Lacayo
  • + 2 authors

6 September 2025

Background: Novel therapies are needed for children, adolescents, and young adults with relapse/refractory leukemia or solid tumors. The proteasome inhibitor carfilzomib has demonstrated pre-clinical activity against several pediatric malignancies wh...

  • Proceeding Paper
  • Open Access
3 Citations
2,635 Views
4 Pages

Cyclophosphamide Inhibits PI3K/AKT/mTOR Signaling Pathway in Mice Kidneys

  • Gulsah Albayrak,
  • Pinar Kilicarslan Sonmez,
  • Damla Akogullari and
  • Elgin Turkoz Uluer

11 December 2018

Cyclophosphamide (CTX), also known as cytophosphane among other, is a medication used as chemotherapy and to suppress the immune system. The PI3K/AKT/mTOR pathway is involved in the regulation of diverse cellular functions, including cell growth, pro...

  • Case Report
  • Open Access
1 Citations
2,016 Views
12 Pages

Sustained Treatment Response after Intravenous Cyclophosphamide in a Patient with Therapy-Resistant COVID-19 Acute Respiratory Distress Syndrome: A Case Report

  • Patrick Haselwanter,
  • Christina Bal,
  • Daniela Gompelmann,
  • Marco Idzko,
  • Helmut Prosch,
  • Christian Zauner and
  • Mathias Schneeweiss-Gleixner

24 August 2023

Treatment of acute respiratory distress syndrome (ARDS) represents a severe complication of coronavirus disease 2019 (COVID-19) infection and is often challenging in intensive care treatment. Potential positive effects of intravenous cyclophosphamide...

  • Article
  • Open Access
12 Citations
3,038 Views
12 Pages

Complementarity between Microbiome and Immunity May Account for the Potentiating Effect of Quercetin on the Antitumor Action of Cyclophosphamide in a Triple-Negative Breast Cancer Model

  • Andrea Manni,
  • Yuan-Wan Sun,
  • Todd D. Schell,
  • Tymofiy Lutsiv,
  • Henry Thompson,
  • Kun-Ming Chen,
  • Cesar Aliaga,
  • Junjia Zhu and
  • Karam El-Bayoumy

6 October 2023

Immunotherapy targeting program cell death protein 1 (PD-1) in addition to chemotherapy has improved the survival of triple-negative breast cancer (TNBC) patients. However, the development of resistance and toxicity remain significant problems. Using...

  • Article
  • Open Access
31 Citations
4,170 Views
14 Pages

Immunomodulatory Activity of Carboxymethyl Pachymaran on Immunosuppressed Mice Induced by Cyclophosphamide

  • Feng Liu,
  • Lijia Zhang,
  • Xi Feng,
  • Salam A. Ibrahim,
  • Wen Huang and
  • Ying Liu

22 September 2021

The effects of immunomodulatory activity of two types of carboxymethyl pachymaran (CMP-1 and CMP-2) on cyclophosphamide (CTX)-induced mice were investigated. Both CMP-1 and CMP-2 were found to restore the splenomegaly and alleviate the spleen lesions...

  • Article
  • Open Access
29 Citations
6,107 Views
13 Pages

Isoliquiritigen Enhances the Antitumour Activity and Decreases the Genotoxic Effect of Cyclophosphamide

  • Hong Zhao,
  • Xuan Yuan,
  • Defang Li,
  • Hongmei Chen,
  • Jiangtao Jiang,
  • Zhiping Wang,
  • Xiling Sun and
  • Qiusheng Zheng

24 July 2013

The aim of this study was to evaluate the antitumour activities and genotoxic effects of isoliquiritigenin (ISL) combined with cyclophosphamide (CP) in vitro and in vivo. U14 cells were treated with either of ISL (5–25 μg/mL) or CP (0.25–1.25 mg/mL)...

  • Article
  • Open Access
365 Views
17 Pages

Plant-Derived Spinacetin Mitigates Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats

  • Jan Wróbel,
  • Łukasz Zapała,
  • Grzegorz Niemczyk,
  • Anna Bogaczyk,
  • Tomasz Kluz,
  • Artur Wdowiak,
  • Aleksandra Misiek,
  • Iwona Bojar,
  • Ewa Poleszak and
  • Andrzej Wróbel
  • + 2 authors

The purpose of our study was to assess if spinacetin (SPC), a flavonoid found in spinach, can alleviate the cyclophosphamide (CYP)-induced changes in cystometric and inflammatory parameters indicative of the development of hemorrhagic cystitis. The a...

  • Article
  • Open Access
12 Citations
3,202 Views
16 Pages

Molecular Iodine/Cyclophosphamide Synergism on Chemoresistant Neuroblastoma Models

  • Winniberg Álvarez-León,
  • Irasema Mendieta,
  • Evangelina Delgado-González,
  • Brenda Anguiano and
  • Carmen Aceves

19 August 2021

Neuroblastoma (Nb), the most common extracranial tumor in children, exhibited remarkable phenotypic diversity and heterogeneous clinical behavior. Tumors with MYCN overexpression have a worse prognosis. MYCN promotes tumor progression by inducing cel...

  • Abstract
  • Open Access
1 Citations
2,405 Views
1 Page

Ameliorative Effects of Carvacrol on Cyclophosphamide-Induced Testis Damage and Oxidative Stress

  • Mustafa Cengiz,
  • Ozgun Teksoy,
  • Varol Sahinturk,
  • Yasemin Tekin,
  • Sibel Gunes and
  • Adnan Ayhanci

15 November 2017

Cyclophosphamide (CP) is an effective drug widely used for treating clinical cancer and non-malignant diseases. However, using CP causes cytotoxicity in one or more tissues. The present study aims to investigate possible protective effects of Carvacr...

  • Article
  • Open Access
79 Citations
8,485 Views
14 Pages

17 October 2018

In this study, the aim was to investigate the effect of bergenin on immune function and antioxidation in cyclophosphamide (Cy)-induced immunosuppressed mice. Firstly, we estimated its effect on immune organs. Histological analysis and indexes of immu...

  • Article
  • Open Access
15 Citations
4,575 Views
23 Pages

Effect of a Low Dose of Carvedilol on Cyclophosphamide-Induced Urinary Toxicity in Rats—A Comparison with Mesna

  • Anna Merwid-Ląd,
  • Piotr Ziółkowski,
  • Marta Szandruk-Bender,
  • Agnieszka Matuszewska,
  • Adam Szeląg and
  • Małgorzata Trocha

29 November 2021

One of the major side effects of cyclophosphamide (CPX)—an alkylating anticancer drug that is still clinically used—is urotoxicity with hemorrhagic cystitis. The present study was designed to evaluate the ability of carvedilol to protect...

  • Article
  • Open Access
31 Citations
8,205 Views
13 Pages

Processed Aloe vera Gel Ameliorates Cyclophosphamide-Induced Immunotoxicity

  • Sun-A Im,
  • Ki-Hyang Kim,
  • Hee-Suk Kim,
  • Ki-Hwa Lee,
  • Eunju Shin,
  • Seon-Gil Do,
  • Tae Hyung Jo,
  • Young In Park and
  • Chong-Kil Lee

24 October 2014

The effects of processed Aloe vera gel (PAG) on cyclophosphamide (CP)-induced immunotoxicity were examined in mice. Intraperitoneal injection of CP significantly reduced the total number of lymphocytes and erythrocytes in the blood. Oral administrati...

  • Article
  • Open Access
9 Citations
2,293 Views
12 Pages

Effect of Flavonols of Aronia melanocarpa Fruits on Morphofunctional State of Immunocompetent Organs of Rats under Cyclophosphamide-Induced Immunosuppression

  • Kseniya Bushmeleva,
  • Alexandra Vyshtakalyuk,
  • Dmitriy Terenzhev,
  • Timur Belov,
  • Evgeniy Nikitin and
  • Vladimir Zobov

Aronia melanocarpa berries contain many compounds with potential benefits for human health. The food flavonoids quercetin and rutin, found in significant amounts in the fruits of A. melanocarpa, are known to have favourable effects on animal and huma...

  • Article
  • Open Access
3 Citations
2,213 Views
21 Pages

12 August 2025

In this study, we evaluated the protective effects of combined melatonin and vitamin D3 treatment on ovarian reserve and tissue architecture in a cyclophosphamide-induced premature ovarian failure (POF) rat model. Forty-nine adult female rats were ra...

  • Article
  • Open Access
23 Citations
4,106 Views
14 Pages

The Role of Cellular Senescence in Cyclophosphamide-Induced Primary Ovarian Insufficiency

  • Zixin Xu,
  • Nozomi Takahashi,
  • Miyuki Harada,
  • Chisato Kunitomi,
  • Akari Kusamoto,
  • Hiroshi Koike,
  • Tsurugi Tanaka,
  • Nanoka Sakaguchi,
  • Yoko Urata and
  • Yutaka Osuga
  • + 2 authors

6 December 2023

Young female cancer patients can develop chemotherapy-induced primary ovarian insufficiency (POI). Cyclophosphamide (Cy) is one of the most widely used chemotherapies and has the highest risk of damaging the ovaries. Recent studies elucidated the piv...

  • Article
  • Open Access
22 Citations
3,363 Views
13 Pages

Phycobiliproteins Ameliorate Gonadal Toxicity in Male Mice Treated with Cyclophosphamide

  • Jorge Briseño-Bugarín,
  • Isabel Hernández-Ochoa,
  • Xelha Araujo-Padilla,
  • María Angélica Mojica-Villegas,
  • Ricardo Iván Montaño-González,
  • Gabriela Gutiérrez-Salmeán and
  • Germán Chamorro-Cevallos

29 July 2021

Cyclophosphamide (CP)—which is used to treat autoimmune diseases and cancer—is related to gonadotoxicity attributed to oxidative stress. As phycobiliproteins (PBPs) are strong antioxidants that are unexplored as protective agents against male gonadot...

  • Article
  • Open Access
6 Citations
2,214 Views
15 Pages

Immunosuppression increases disease risk, and the natural compound polydatin (PD) has been reported to modulate immune-related disorders. In cyclophosphamide-induced immunosuppressed mice, PD was evaluated for its immunomodulatory effects. Immune org...

  • Article
  • Open Access
19 Citations
7,285 Views
9 Pages

Effect of the Molecular Mass of Tremella Polysaccharides on Accelerated Recovery from Cyclophosphamide-Induced Leucopenia in Rats

  • Rui-Zhi Jiang,
  • Ying Wang,
  • Hao-Ming Luo,
  • Yan-Qiu Cheng,
  • Ying-Hong Chen,
  • Yang Gao and
  • Qi-Pin Gao

23 March 2012

The body of tremella were decocted with water, and hydrolyzed with 0.1 mol/L hydrochloric acid for different times, giving tremella polysaccharides with six molecular mass values. The structures of all the tremella polysaccharides had non-reducing te...

  • Article
  • Open Access
23 Citations
3,675 Views
12 Pages

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer

  • Piotr J. Wysocki,
  • Mateusz Łobacz,
  • Paweł Potocki,
  • Łukasz Kwinta,
  • Anna Michałowska-Kaczmarczyk,
  • Agnieszka Słowik,
  • Kamil Konopka and
  • Anna Buda-Nowak

7 February 2023

Patients with advanced ovarian cancer (OC) have a detrimental prognosis. The options for systemic treatment of advanced OC in later lines of treatment are limited by the availability of active therapies and their applicability to often fragile, exhau...

  • Article
  • Open Access
1 Citations
2,254 Views
10 Pages

The Uroprotective Efficacy of Total Ginsenosides in Chinese Ginseng on Chemotherapy with Cyclophosphamide

  • Yung-Hsiang Chen,
  • Wen-Chi Chen,
  • Szu-Ju Chen,
  • Shih-Jing Wang,
  • Po-Len Liu,
  • Ming-Yen Tsai,
  • Chun-Ting Liu,
  • Der-Cherng Chen and
  • Huey-Yi Chen

4 August 2022

Hemorrhagic cystitis is a recognizable complication of cyclophosphamide (CYP) attributable to its lively metabolite acrolein, which produces urothelial injury. The study intended to examine the uroprotective efficacy of total ginsenosides in Chinese...

  • Article
  • Open Access
96 Citations
8,540 Views
8 Pages

Follicle Loss and Apoptosis in Cyclophosphamide-Treated Mice: What’s the Matter?

  • Xiu-Ying Chen,
  • He-Xia Xia,
  • Hai-Yun Guan,
  • Bin Li and
  • Wei Zhang

With increasing numbers of young female cancer survivors following chemotherapy, chemotherapy-induced fertility loss must be considered. Menstrual disorder and infertility are of particular concern in female cancer patients. We showed that treatment...

  • Article
  • Open Access
7 Citations
3,509 Views
13 Pages

13 May 2022

Hemomine is an herbal blend comprising Angelicae Gigantis Radix and other herbs known to have immunomodulatory effects. We examined the immunopotentiating effect of this herbal blend on cyclophosphamide (CPA)-induced immunosuppression. Male mice were...

  • Article
  • Open Access
18 Citations
7,940 Views
20 Pages

Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells

  • Maria Pereira-Oliveira,
  • Ana Reis-Mendes,
  • Félix Carvalho,
  • Fernando Remião,
  • Maria de Lourdes Bastos and
  • Vera Marisa Costa

10 January 2019

Currently, a common therapeutic approach in cancer treatment encompasses a drug combination to attain an overall better efficacy. Unfortunately, it leads to a higher incidence of severe side effects, namely cardiotoxicity. This work aimed to assess t...

  • Article
  • Open Access
24 Citations
7,134 Views
12 Pages

5 February 2020

Cyclophosphamide (CP) is a well-known antineoplastic agent; however, its clinical use can be associated with various organ toxicities. Evening primrose oil (EPO) contains several phytoconstituents with potent anti-oxidant and anti-inflammatory activi...

  • Article
  • Open Access
7 Citations
2,682 Views
14 Pages

1 September 2023

A lipid extract was obtained from eggs of the sailfin sandfish, Arctoscopus japonicus. Immunostimulatory effects of A. japonicus lipids incorporated with PEG6000 (AJ-PEG) on immunosuppressed mice treated with cyclophosphamide (CY) were investigated....

  • Review
  • Open Access
41 Citations
20,078 Views
13 Pages

28 September 2020

Although cyclophosphamide (CP) has been used successfully in the clinic for over 50 years, it has so far not been possible to elucidate the mechanism of action and to use it for improvement. This was not possible because the basis of the mechanism of...

  • Article
  • Open Access
27 Citations
5,083 Views
10 Pages

Influence of Modified Fucoidan and Related Sulfated Oligosaccharides on Hematopoiesis in Cyclophosphamide-Induced Mice

  • Natalia Yu. Anisimova,
  • Nadezhda E. Ustyuzhanina,
  • Maria I. Bilan,
  • Fedor V. Donenko,
  • Natalia A. Ushakova,
  • Anatolii I. Usov,
  • Mikhail V. Kiselevskiy and
  • Nikolay E. Nifantiev

13 September 2018

Immunosuppression derived after cytostatics application in cancer chemotherapy is considered as an adverse side effect that leads to deterioration of quality of life and risk of infectious diseases. A linear sulfated (1→3)-α-l-fucan M-Fuc...

  • Article
  • Open Access
2 Citations
2,232 Views
10 Pages

Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment

  • Shiyuan Zhou,
  • Yingying Zhai,
  • Lingzhi Yan,
  • Xiaolan Shi,
  • Jingjing Shang,
  • Depei Wu,
  • Chengcheng Fu and
  • Song Jin

27 September 2023

Background: Melphalan was poorly available in mainland China. The aim of this study is to explore the dose-adjusted busulfan/cyclophosphamide (BU/CY) as an alternative regimen in auto stem cell transplantation (ASCT) for multiple myeloma (MM). Method...

  • Article
  • Open Access
29 Citations
5,165 Views
10 Pages

The Protective Effects of Sesamin against Cyclophosphamide-Induced Nephrotoxicity through Modulation of Oxidative Stress, Inflammatory-Cytokines and Apoptosis in Rats

  • Saeed Alshahrani,
  • Hani M. Ali Thubab,
  • Abdulrahman M. Ali Zaeri,
  • Tarique Anwer,
  • Rayan A. Ahmed,
  • Abdulmajeed M. Jali,
  • Marwa Qadri,
  • Yousra Nomier,
  • Sivakumar S. Moni and
  • Mohammad F. Alam

1 October 2022

Cyclophosphamide is an anticancer drug with a wide spectrum of clinical uses, but its typical side effects are multiple complications, including nephron toxicity. The possible molecular mechanism of the nephroprotective action of sesamin (SM) against...

of 17